View in EDS

Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial.

Saved in:
Bibliographic Details
Title: Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial.
Authors: Yau T; The University of Hong Kong, Hong Kong, China., Zagonel V; Oncology Unit 1, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy., Santoro A; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.; IRCCS Humanitas Research Hospital-Humanitas Cancer Center, Rozzano, Italy., Acosta-Rivera M; Fundacion de Investigación, San Juan, Puerto Rico., Choo SP; National Cancer Center and Curie Oncology, Singapore., Matilla A; Servicio de Digestivo, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; CIBEREHD, Madrid, Spain., He AR; Georgetown University Hospital, Washington, DC., Cubillo Gracian A; Hospital HM Universitario Sanchinarro, Centro Integral Oncológico Clara Campal (HM-CIOCC), Madrid, Spain.; Departamento de Ciencias Médicas Clínicas, Universidad Camilo José Cela, Madrid, Spain., El-Khoueiry AB; USC Norris Comprehensive Cancer Center, Los Angeles, CA., Sangro B; Clinica Universidad de Navarra and CIBEREHD, Pamplona, Spain., Eldawy TE; Sacred Heart Health Systems, Pensacola, FL., Bruix J; BCLC Group, Liver Unit, Hospital Clínic-IDIBAPS, University of Barcelona, CIBEREHD, Barcelona, Spain., Frassineti GL; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori,' Meldola, Italy., Vaccaro GM; Providence Cancer Institute, Portland, OR., Tschaika M; Bristol Myers Squibb, Princeton, NJ., Scheffold C; Exelixis, Inc, Alameda, CA., Koopmans P; Bristol Myers Squibb, Princeton, NJ., Neely J; Bristol Myers Squibb, Princeton, NJ., Piscaglia F; Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Mar 20; Vol. 41 (9), pp. 1747-1757. Date of Electronic Publication: 2022 Dec 13.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36512738
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yau+T%22">Yau T</searchLink>; The University of Hong Kong, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Zagonel+V%22">Zagonel V</searchLink>; Oncology Unit 1, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Santoro+A%22">Santoro A</searchLink>; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.; IRCCS Humanitas Research Hospital-Humanitas Cancer Center, Rozzano, Italy.<br /><searchLink fieldCode="AU" term="%22Acosta-Rivera+M%22">Acosta-Rivera M</searchLink>; Fundacion de Investigación, San Juan, Puerto Rico.<br /><searchLink fieldCode="AU" term="%22Choo+SP%22">Choo SP</searchLink>; National Cancer Center and Curie Oncology, Singapore.<br /><searchLink fieldCode="AU" term="%22Matilla+A%22">Matilla A</searchLink>; Servicio de Digestivo, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; CIBEREHD, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22He+AR%22">He AR</searchLink>; Georgetown University Hospital, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Cubillo+Gracian+A%22">Cubillo Gracian A</searchLink>; Hospital HM Universitario Sanchinarro, Centro Integral Oncológico Clara Campal (HM-CIOCC), Madrid, Spain.; Departamento de Ciencias Médicas Clínicas, Universidad Camilo José Cela, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22El-Khoueiry+AB%22">El-Khoueiry AB</searchLink>; USC Norris Comprehensive Cancer Center, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Sangro+B%22">Sangro B</searchLink>; Clinica Universidad de Navarra and CIBEREHD, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Eldawy+TE%22">Eldawy TE</searchLink>; Sacred Heart Health Systems, Pensacola, FL.<br /><searchLink fieldCode="AU" term="%22Bruix+J%22">Bruix J</searchLink>; BCLC Group, Liver Unit, Hospital Clínic-IDIBAPS, University of Barcelona, CIBEREHD, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Frassineti+GL%22">Frassineti GL</searchLink>; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori,' Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22Vaccaro+GM%22">Vaccaro GM</searchLink>; Providence Cancer Institute, Portland, OR.<br /><searchLink fieldCode="AU" term="%22Tschaika+M%22">Tschaika M</searchLink>; Bristol Myers Squibb, Princeton, NJ.<br /><searchLink fieldCode="AU" term="%22Scheffold+C%22">Scheffold C</searchLink>; Exelixis, Inc, Alameda, CA.<br /><searchLink fieldCode="AU" term="%22Koopmans+P%22">Koopmans P</searchLink>; Bristol Myers Squibb, Princeton, NJ.<br /><searchLink fieldCode="AU" term="%22Neely+J%22">Neely J</searchLink>; Bristol Myers Squibb, Princeton, NJ.<br /><searchLink fieldCode="AU" term="%22Piscaglia+F%22">Piscaglia F</searchLink>; Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2023 Mar 20; Vol. 41 (9), pp. 1747-1757. <i>Date of Electronic Publication: </i>2022 Dec 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36512738
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO.22.00972
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1747
    Titles:
      – TitleFull: Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yau T
      – PersonEntity:
          Name:
            NameFull: Zagonel V
      – PersonEntity:
          Name:
            NameFull: Santoro A
      – PersonEntity:
          Name:
            NameFull: Acosta-Rivera M
      – PersonEntity:
          Name:
            NameFull: Choo SP
      – PersonEntity:
          Name:
            NameFull: Matilla A
      – PersonEntity:
          Name:
            NameFull: He AR
      – PersonEntity:
          Name:
            NameFull: Cubillo Gracian A
      – PersonEntity:
          Name:
            NameFull: El-Khoueiry AB
      – PersonEntity:
          Name:
            NameFull: Sangro B
      – PersonEntity:
          Name:
            NameFull: Eldawy TE
      – PersonEntity:
          Name:
            NameFull: Bruix J
      – PersonEntity:
          Name:
            NameFull: Frassineti GL
      – PersonEntity:
          Name:
            NameFull: Vaccaro GM
      – PersonEntity:
          Name:
            NameFull: Tschaika M
      – PersonEntity:
          Name:
            NameFull: Scheffold C
      – PersonEntity:
          Name:
            NameFull: Koopmans P
      – PersonEntity:
          Name:
            NameFull: Neely J
      – PersonEntity:
          Name:
            NameFull: Piscaglia F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 03
              Text: 2023 Mar 20
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1